Q

uniQure NV

QURE

7.51000
USD
-0.145
(-1.89%)
Market Open
Volume
16,833
EPS
0
Div Yield
0
P/E
-1
Market Cap
318,969,404
Related Instruments
A
ALNY
31.19
(13.13%)
268.66 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
B
BLUE
-0.06000
(-5.26%)
1.08000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
GILD
0.470
(0.62%)
76.510 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
News

Title: uniQure NV

Sector: Healthcare
Industry: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.